[HTML][HTML] Prostate cancer radiogenomics—from imaging to molecular characterization

M Ferro, O de Cobelli, MD Vartolomei… - International Journal of …, 2021 - mdpi.com
Radiomics and genomics represent two of the most promising fields of cancer research,
designed to improve the risk stratification and disease management of patients with prostate …

Non-coding RNAs in endometriosis: a narrative review

K Panir, JE Schjenken, SA Robertson… - Human reproduction …, 2018 - academic.oup.com
BACKGROUND Endometriosis is a benign gynaecological disorder, which affects 10% of
reproductive-aged women and is characterized by endometrial cells from the lining of the …

Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings

A Algohary, S Viswanath, R Shiradkar… - Journal of Magnetic …, 2018 - Wiley Online Library
Background Radiomic analysis is defined as computationally extracting features from
radiographic images for quantitatively characterizing disease patterns. There has been …

A urinary biomarker‐based risk score correlates with multiparametric MRI for prostate cancer detection

RJ Hendriks, MMG van der Leest, S Dijkstra… - The …, 2017 - Wiley Online Library
Background Prostate cancer (PCa) diagnostics would greatly benefit from more accurate,
non‐invasive techniques for the detection of clinically significant disease, leading to a …

[HTML][HTML] Genetic landscape of prostate cancer conspicuity on multiparametric magnetic resonance imaging: a systematic review and bioinformatic analysis

JM Norris, BS Simpson, MA Parry, C Allen… - European Urology Open …, 2020 - Elsevier
Context Multiparametric magnetic resonance imaging (mpMRI) detects most, but not all,
clinically significant prostate cancer. The genetic basis of prostate cancer visibility and …

A review on the role of PCA3 lncRNA in carcinogenesis with an especial focus on prostate cancer

S Ghafouri-Fard, T Khoshbakht, BM Hussen… - … -Research and Practice, 2022 - Elsevier
The prostate cancer antigen 3 (PCA3) is a long non-coding RNA (lncRNA) with high level of
specificity for prostate cancer. This lncRNA has fundamental effects in the prostate …

Incorporating biomarkers into the primary prostate biopsy setting: a cost-effectiveness analysis

NJ Sathianathen, KM Kuntz, F Alarid-Escudero… - Journal of …, 2018 - journals.lww.com
Purpose: We performed a cost-effectiveness analysis using the PHI (Prostate Health Index),
4Kscore®, SelectMDx™ and the EPI (ExoDx™ Prostate [IntelliScore]) in men with elevated …

[HTML][HTML] A predictive model for prostate cancer incorporating PSA molecular forms and age

J Oto, Á Fernández-Pardo, M Royo, D Hervás… - Scientific Reports, 2020 - nature.com
The diagnostic specificity of prostate specific antigen (PSA) is limited. We aimed to
characterize eight anti-PSA monoclonal antibodies (mAbs) to assess the prostate cancer …

[HTML][HTML] Radiogenomics analysis linking multiparametric MRI and transcriptomics in prostate cancer

C Dinis Fernandes, A Schaap, J Kant, P van Houdt… - Cancers, 2023 - mdpi.com
Simple Summary Prostate cancer is a global health burden. Multi-parametric magnetic
resonance imaging is the recommended imaging modality for diagnosis. The recommended …

An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer

S Brönimann, B Pradere, P Karakiewicz… - Expert Review of …, 2020 - Taylor & Francis
Introduction This manuscript aims to give an overview of current diagnostic, staging, and
prognostic markers for prostate cancer (PCa) and discuss emerging approaches. The …